The clinical benefit in patients with lupus nephritis was based on the ... Overuse of concomitant steroids and continued treatment with immunosuppressive drugs almost certainly made a large ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

Lupkynis (voclosporin) can be used in combination with the immunosuppressant drug mycophenolate mofetil (MMF) as an option for adults at the more severe end of the lupus nephritis spectrum ...

Systemic lupus erythematosus is a potentially fatal ... Patients are treated with immunosuppressive drugs. During the past year, four studies have reported ten mutations in UNC93B1, which encodes ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

For severe cases or when organ systems are involved, treatment may include: Immunosuppressive drugs: Medications such as azathioprine, methotrexate, cyclosporine, mycophenolate mofetil, and ...

People often take drugs for life if they have lupus, ranging from ibuprofen to steroid tablets and injections, or other immunosuppressant or biological medicines. According to the NHS, those with ...

DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline ...

The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.